Urist Marshall — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Urist Marshall has filed 5 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $4.88M.

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-02RPRXRoyalty Pharma plcS — Open-market sale9.1K$55.88$508K
2026-06-25RPRXRoyalty Pharma plcS — Open-market sale9.1K$55.18$502K
2026-05-22RPRXRoyalty Pharma plcS — Open-market sale13.7K$52.75$722K
2026-05-15RPRXRoyalty Pharma plcS — Open-market sale13.7K$53.06$726K
2026-05-08RPRXRoyalty Pharma plcA — Grant or award18.2K$0.00
2026-02-13RPRXRoyalty Pharma plcA — Grant or award20.0K$0.00
2026-02-02RPRXRoyalty Pharma plcS — Open-market sale [10b5-1]20.0K$41.09$822K
2026-01-26RPRXRoyalty Pharma plcS — Open-market sale [10b5-1]20.0K$40.26$805K
2026-01-20RPRXRoyalty Pharma plcS — Open-market sale [10b5-1]20.0K$39.52$790K
2025-08-06RPRXRoyalty Pharma plcA — Grant or award2.8K$0.00

Companies — Last 90 Days

Frequently Asked Questions

Who is Urist Marshall?

Urist Marshall is a corporate insider — currently tracked as EVP, Research & Investments of Royalty Pharma plc (RPRX). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has Urist Marshall submitted recently?

5 primary Form 4 filings in the last 90 days, covering 1 company.

Has Urist Marshall been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 7 open-market sales ($4.88M) across all tracked filings.

Where can I see all of Urist Marshall's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Urist Marshall profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.